Carter Bankshares Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

Carter Bankshares hat eine Bilanzsumme von $4.5B und ein Eigenkapital von $364.4M. Die Gesamteinlagen belaufen sich auf $3.9B und die Gesamtkredite auf $3.5B, was zu einer Nettozinsmarge von 2.9% führt. Die Wertberichtigungen für notleidende Kredite sind unzureichend und belaufen sich derzeit auf 8.5% der Gesamtkredite. Die Barmittel und kurzfristigen Anlagen betragen $81.3M.

Wichtige Informationen

12.4x

Verhältnis von Vermögen zu Eigenkapital

2.9%

Nettozinsspanne

Gesamteinlagen	US$3.88b
Kredit- zu Einlagenverhältnis	Angemessen
Notleidende Kredite	8.5%
Wertberichtigung für notleidende Kredite	Niedrig
Liquiditätskennzahl	Niedrig
Bargeld und Äquivalente	US$81.34m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Analysts Just Made A Major Revision To Their Carter Bankshares, Inc. (NASDAQ:CARE) Revenue Forecasts

Aug 01

It Looks Like Carter Bankshares, Inc.'s (NASDAQ:CARE) CEO May Expect Their Salary To Be Put Under The Microscope

Jun 17

Would Shareholders Who Purchased Carter Bankshares' (NASDAQ:CARE) Stock Three Years Be Happy With The Share price Today?

Mar 05

How Much Are Carter Bankshares, Inc. (NASDAQ:CARE) Insiders Taking Off The Table?

Jan 28

Carter Bank inks agreement with Pendleton Community Bank

Jan 14

Carter Bank & Trust  EPS of -$2.19

Oct 29

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Analyse der Finanzinstitute

Vermögensebene: CAREDas Verhältnis von Vermögen zu Eigenkapital (12.7x) ist moderat.

Wertberichtigung für uneinbringliche Kredite: CARE hat eine niedrige Wertberichtigung für notleidende Kredite (31%).

Verbindlichkeiten mit geringem Risiko: 91% der Verbindlichkeiten von CARE bestehen hauptsächlich aus risikoarmen Finanzierungsquellen.

Darlehenshöhe: CARE ein angemessenes Niveau des Verhältnis von Krediten zu Vermögenswerten aufweist (75%).

Einlagen mit geringem Risiko: CAREDas Verhältnis von Krediten zu Einlagen (89%) ist angemessen.

Höhe der notleidenden Kredite: CARE hat einen hohen Anteil an faulen Krediten (8.8%).

Carter Bankshares Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Price target increased by 18% to US$20.00

Second quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improves as stock rises 20%

Price target decreased by 12% to US$15.00

Consensus EPS estimates increase by 155%

Carter Bankshares, Inc., Annual General Meeting, May 22, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 27%, revenue downgraded

Carter Bankshares, Inc. Introduces Carter Zescrow

Consensus EPS estimates increase by 151%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.2% to US$15.25

Carter Bankshares, Inc. Reports Unaudited Net Charge Offs for the Third Quarter Ended September 30, 2023

Third quarter 2023 earnings: EPS misses analyst expectations

New major risk - Revenue and earnings growth

Consensus revenue estimates fall by 18%

Analysts Just Made A Major Revision To Their Carter Bankshares, Inc. (NASDAQ:CARE) Revenue Forecasts

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Insider selling

High number of new directors

Price target decreased by 8.4% to US$18.08

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorates as stock falls 21%

Carter Bankshares, Inc. Reports Net Charge-Offs for the Fourth Quarter Ended December 31, 2022

Full year 2022 earnings released: EPS: US$2.04 (vs US$1.19 in FY 2021)

Carter Bankshares, Inc. Announces Executive Changes

Price target increased to US$21.00

Third quarter 2022 earnings released: EPS: US$0.59 (vs US$0.42 in 3Q 2021)

Carter Bankshares, Inc. Reports Net Charge-Offs for the Third Quarter Ended September 30, 2022

Consensus EPS estimates increase by 16%

Second quarter 2022 earnings released: EPS: US$0.44 (vs US$0.20 in 2Q 2021)

Price target decreased to US$17.83

First quarter 2022 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

An unknown buyer acquired 16 Branches of Carter Bankshares, Inc.

Independent Director recently bought US$90k worth of stock

Price target increased to US$17.25

Third quarter 2021 earnings released: EPS US$0.42 (vs US$2.19 loss in 3Q 2020)

Price target increased to US$16.75

Second quarter 2021 earnings released: EPS US$0.21 (vs US$0.17 in 2Q 2020)

It Looks Like Carter Bankshares, Inc.'s (NASDAQ:CARE) CEO May Expect Their Salary To Be Put Under The Microscope

Price target increased to US$15.92

First quarter 2021 earnings released: EPS US$0.36 (vs US$0.17 in 1Q 2020)

Price target increased to US$14.58

Carter Bankshares, Inc. Announces Retirement of Charles E. Hall as Director

Carter Bankshares, Inc., Annual General Meeting, Jun 23, 2021

Revenue beats expectations

Full year 2020 earnings released: US$1.74 loss per share (vs US$1.01 profit in FY 2019)

Would Shareholders Who Purchased Carter Bankshares' (NASDAQ:CARE) Stock Three Years Be Happy With The Share price Today?

New 90-day high: US$12.05

Full year 2020 earnings released: US$1.74 loss per share (vs US$1.01 profit in FY 2019)

Revenue beats expectations

Farmers & Merchants Bank agreed to acquire operations of Branch Office in Waynesboro, Virginia of Carter Bankshares, Inc.

How Much Are Carter Bankshares, Inc. (NASDAQ:CARE) Insiders Taking Off The Table?

Price target raised to US$12.58

New 90-day high: US$12.02

Carter Bank inks agreement with Pendleton Community Bank

New 90-day high: US$11.00

New 90-day high: US$10.01

Price target raised to US$10.17

Analysts lower EPS estimates to -US$1.75

New 90-day high: US$7.95

Third quarter 2020 earnings released: US$2.19 loss per share

Revenue and earnings miss expectations

Carter Bank &amp; Trust&nbsp; EPS of -$2.19

New 90-day low: US$6.83

First half earnings released

Price target lowered to US$9.25

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Analyse der Finanzinstitute

Entdecken Sie finanziell stabile Unternehmen

Carter Bank & Trust EPS of -$2.19